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  ABSTRACT 
Background: Asthma is one of the most common chronic conditions among children 
and is the third leading cause of pediatric hospitalization among children under age 15. 
Asthma-related emergency department (ED) visits are common and expensive to the 
health system. One of the proposed cost savings measures is for hospitals to hire care 
managers who can coordinate care for individuals with chronic diseases such as 
asthma, for example by educating families about general preventative care practices, 
reconciling medications, and answering questions. It would be valuable to 
prospectively identify children likely to be frequent ED users, in order to enroll in care 
management programs. It is unclear if electronic health record (EHR) data can be used 
to predict which patients will frequently use the ED for asthma. 
Objective: To explore the predictability of frequent ED use among pediatric asthma 
patients in New York City using data from an EHR from one medical center.  
Methods: We performed a literature review and interviewed 5 physicians affiliated 
with Weill Cornell Medical Center to generate a list of potential predictors of ED use. 
We operationalized a subset of these predictors from an EHR system. We performed 
bivariate statistics to examine the unadjusted relationship between each variable and 
frequent ED use.  Then we evaluated and compared the performance of several 
machine-learning algorithms to predict which children with asthma will use the ED 
two or more times in the next year. The algorithms we used were: logistic regression 
best subsets, Least Absolute Shrinkage and Selection Operator (LASSO) regression, 
Random Forests, Classification and Regression Trees (CART), and Support Vector 
Machines (SVM). We evaluated model performance based on Area Under the Curve 
	  (AUC), positive predictive value (PPV), sensitivity, calibration, and classification 
error.  
Results: We operationalized 52 predictors. Bivariate analysis showed significant 
associations between many of the clinical and demographic predictors and frequent 
ED use. All the predictive algorithms performed similarly, with very good area under 
the curve (AUC) values, but poor positive predictive value and sensitivity. We 
selected a two variable model as our final model based on the predictors that appeared 
significant across the algorithms: number of ED visits in the previous year and type of 
insurance. Publicly insured patients with asthma who used the ED four or more times 
in the baseline year have a 50% or greater probability of being a frequent ED user in 
the following year. The same utilization pattern is seen among privately insured 
patients who have six or more ED visits in the baseline year.  
Conclusions: Children who are currently frequent users of the ED are likely to 
continue to do so.  The threshold for identifying these children is lower among 
children with public insurance compared to those with private insurance.  A two 
variable (prior ED visits and insurance status) model to predict which children with 
asthma will be future ED users is as accurate as predictions from several machine 
learning algorithms. These observations can be used to identify children with asthma 
who may benefit from enrollment in a care management program, using data from an 
EHR. 
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CHAPTER ONE 
INTRODUCTION 
 
Asthma is one of the most common chronic conditions among children and is 
the third leading cause of pediatric hospitalization among patients under the age of 
15.1 More than 7.1 million (over 10%) children living in the United States had asthma 
in 2011.2 Half of children with asthma have at least one exacerbation per year, which 
often necessitate ED visits and inpatient hospital admissions.3 In 2010 alone, there 
were 640,000 asthma-related pediatric ED visits.1 
 
Pediatric asthma care is expensive to the US healthcare system. In 2007, the 
U.S. spent over $56 billion on asthma care, half of this on pediatric asthma alone.4 
State Medicaid programs combined spent in excess of $272 million on pediatric 
asthma-related ED visits in the United States in 2010.5 Importantly, patients with 
poorly controlled severe asthma cost nearly $5000 more per patient per year compared 
to average pediatric asthma costs.6  
 
Asthma is an ambulatory care sensitive condition,7 which implies that timely 
and effective ambulatory care can reduce emergency department (ED) visits and 
hospitalizations. High quality outpatient care might include providing education to 
patients and their family members, controlling disease severity with daily medication, 
helping families make lifestyle adjustments to avoid triggers, and managing acute 
exacerbations in the home or in an office setting. Frequent ED visits for asthma and 
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high rates of inpatient hospitalization in a community may indicate insufficient 
preventative measures, shortage of primary care access, or poor performance of care 
delivery systems. One strategy that has the potential to improve disease control is the 
implementation of targeted care management (CM).  
 
In order to reduce preventable ED use, many healthcare organizations have 
created CM teams.8 Care managers work directly with patients to coordinate care 
services associated with hospital discharge, provide information about their disease 
and preventive care measures, reconcile medications, answer post-hospitalization 
follow-up questions, and manage treatment-related services with other healthcare 
providers.8 Well-implemented care management programs can reduce hospital use, 
lower costs, and improve clinical outcomes for patients with chronic diseases.9,10 
Despite these positive outcomes, identification of the best patient cohort for potential 
enrollment in CM programs remains a challenge due to insufficient published research 
and a lack of consensus among administrators, healthcare providers, and policy 
experts to guide enrollment strategy. 
 
Given the challenges associated with patient cohort identification, one 
proposed way to better identify patients at-risk for frequent ED use is to use predictive 
modeling techniques.11 A predictive model takes quantifiable data elements from a 
patient’s medical history and makes a prediction about future healthcare use, such as 
ED use. Predictive models may use classical methods like regression or more 
sophisticated machine learning techniques to predict outcomes. Predictive models can 
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generate a risk score to identify patients likely to make frequent ED visits based their 
medical history. Subsequently, a risk score threshold can be used to determine a 
patient’s inclusion or exclusion into CM programs. Frequent ED use can also be 
predicted in a binary sense; that is, the model will predict the outcome as “yes” or 
“no”. Patients who are predicted to be frequent ED users may be enrolled in CM. 
 
Investigators have used PM to identify several factors among children with 
asthma that are associated with frequent ED use. These factors include prior healthcare 
utilization history,12 demographics,13 co-morbidities,14 insurance status,15 and 
medication history.16 For example, frequency of asthma-related ED visit in the 
previous year was associated with the frequency of asthma-related ED visit in the 
following year.12 Another study showed that controller-to-asthma medication ratio 
significantly predicted frequency of future ED visit, and hospitalization.16 A recent 
study also found that living in a single-parent home, having a disability related to 
asthma, and asthma severity are significant predictors of frequent ED visits.13 
However, a 2011 review found that many risk prediction models have only modest 
levels of accuracy.17  
 
In the past, most investigators have used regression as a predictive modeling 
tool. While there are several benefits of using regression, there are important 
limitations. For example, regression techniques have difficulties accounting for 
missing data, large numbers of variables, non-linear relationships between variables, 
and unusual distributions – all commonly seen in healthcare data. Since then, 
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significant efforts have been made to optimize predictive performance by using newer 
techniques that can better handle the limitations associated with regression. The results 
have shown slight improvements in discriminative accuracies,18-21 warranting more 
research.  
 
Modeling outcomes, however, depend not only on analytic methods but also on 
the quality of the data source and the extent of accessible data elements. Many studies 
use administrative data from statewide or national databases.22 While there are some 
advantages to this approach such as ease of availability, greater number of subjects, 
and easier assessment of medication compliance, there is very limited information 
available about clinical factors pertaining to patients in administrative datasets. 
Clinical factors may be crucial to better understanding patient’s health utilization 
patterns. Thus, an alternative approach is to use data from electronic health records 
(EHRs). In addition to many of the data elements available in administrative datasets, 
such as visit history and diagnosis codes, EHRs contain detailed clinical information 
such as lab test results, medical comorbidities, and disease severity.23  
 
In this study, we explore the predictability of frequent ED use among pediatric 
patients in New York City using data from an EHR from one medical center. Our 
goals were twofold. First, we created and validated a database of factors derived from 
an EHR system that are known or presumed to predict frequent ED use among 
pediatric asthma patients.  Our second goal was to evaluate and compare the 
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performance of several machine-learning algorithms to predict which children with 
asthma will use the ED four or more times in the next year.  
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CHAPTER TWO 
METHODS 
Study Design Overview. We performed a retrospective cohort study in order to 
investigate factors associated with frequent ED use. Patients’ healthcare utilization 
data for predictive modeling were collected for years 2013 (Year 1) and 2014 (Year 2) 
using the outpatient EHR of one medical center in New York City. The Weill Cornell 
Medical Center Institutional Review Board approved the study.  
 
Potential Predictors. We performed a literature search to identify reported predictors 
of frequent ED use among pediatric asthma patients. In addition, in order to make a 
more comprehensive list of predictors for predictive modeling, we interviewed a 
convenience sample of physicians who were affiliated with Weill Cornell Medical 
College and had clinical experience working with pediatric asthma patients. 
The interviews were semi-structured. Examples of questions we asked all physicians 
were: (1) What do you think are the common reasons why children with asthma 
frequently use the ED? (2) What socio-demographic factors contribute to frequent ED 
use? (3) What clinical markers, in your opinion, may correlate with frequent ED use 
among children with asthma? Specific follow-up questions were asked based on their 
responses. We took hand-written notes during the interviews that were later used to 
compile and generate a list of potential predictors. 
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Inclusion Criteria. We included all individuals below 18 years of age who were 
patients at Weill Cornell Medical Center’s outpatient clinic, prescribed Albuterol or 
Xopenex, or with an ICD-9 code of 493.x (asthma) in 2013.24 
 
Predictor Variables. Data for each patient included demographic variables such as age, 
sex, race and ethnicity, borough of New York, type of insurance, access to primary 
care physician, prior health service utilization history like number of ED, medical 
complexity using the Pediatric Medical Complexity Algorithm (PMCA),25 inpatient, 
and outpatient visits, clinical factors such as Body Mass Index (BMI), IgE blood test, 
dependence on technology for asthma care, and allergies, variables for psychiatric and 
medical comorbidities, and medication usage.   
 
Outcome. We define frequent ED use as ≥ 2 ED visits.  This is less than the more 
common definition of 4+ visits,26-28 which was a very rare event in our data (1.5% of 
patients). 
 
Bivariate Analysis. We investigated associations between predictor variables and the 
frequent (2+) ED visits in Year 2. We performed Pearson’s correlation test for 
continuous predictor variables. For categorical predictors, we used the Chi-squared 
test.  
 
Predictive Modeling Strategy.  We used two modified regression techniques, both of 
which provide easily interpretable results. We also used two decision tree algorithms 
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and support vector machines which are more challenging to interpret, but have the 
potential to provide more accurate predictions.  
 
We randomly split the data in half, creating a training and test set. We applied the 
following techniques to the training set: 
 
Logistic Regression, Best Subsets. We created 1,2, and 3-variable models 
using the best subsets algorithm and logistic regression. This technique 
identifies the best-fitting regression model by examining all combinations of 
predictor variables that are specified. This technique is computationally 
feasible for large numbers of variables when the total the number of allowed 
predictor variables is restricted to a smaller number.29 
 
Regularized Logistic Regression, Lasso. The LASSO (Least Absolute 
Shrinkage and Selection Operator) is a regression method that involves 
penalizing the absolute size of regression coefficients, as they grow too large. 
By constraining the sum of the absolute values of the estimates, some of the 
parameter estimates become zero, thereby limiting the number of variables in 
the final model. The LASSO requires a parameter λ, which we determined via 
cross-validation within the training set. 29,30 
 
Decision Trees. We used two decision tree algorithms. CART (Classification 
and Regression Tree) algorithm constructs and prunes a decision tree 
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automatically.31 Since our outcome variable is binary, we used the 
classification method in our algorithm. Random Forests builds a series of trees 
using random subsets of the training data.32 When a new example is introduced, 
each tree of the Random Forest “votes” on the outcome. The outcome with the 
majority vote is the final prediction.  
 
Geometric. Support vector machines is a supervised learning model based on 
geometric principles. The algorithm represents every example, belonging to 
one of two categories, as a point in space such that examples of either category 
are separated by a clear gap that is as wide as possible. When a new example is 
introduced the predicted outcome is determined based on which side of the gap 
it appears.33 
 
Evaluation of Models.  After building the models with the training set data, we 
evaluated models chosen by each technique on the test set using the following criteria: 
(1) area under the receiver operating curve (AUC), (2) calibration error, (3) 
classification error, (4) sensitivity, and (5) positive predictive value (PPV). Calibration 
error is defined as the measurement of mean absolute error between predicted 
probability and observed proportion calculated as follows:  
a) Split individuals into 5 groups, based on evenly distributed bins of 
predicted probability (i.e. 0-20%, >20-40%, etc.) 
b) Calculate the mean absolute difference between the predicted probability 
and the observed proportion of frequent ED use, across these 5 groups. 
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Classification error was defined as (1-Accuracy) * 100, where Accuracy is defined as 
percentage of times the predicted outcome is equal to the observed outcome.  
 
The following rubric was used to evaluate each technique’s model AUC, sensitivity, 
and PPV: <0.6 poor, 0.6-0.69 fair, 0.7-0.79 good, 0.8-0.89 very good, and 0.9-1.0 
excellent. For calibration and classification error evaluation, we use the following 
rubric: 0-4% excellent, 5-9% very good, 10-14% good, 15-20% fair, and >20% poor.  
 
Model Selection. We selected a final model based on sparsity (i.e. small number of 
variables), accuracy, and interpretability.    
 
Additional Analysis.  Based on the variables in the final model, we performed an 
additional analysis to investigate the relationship between ED visits in the baseline 
year and ED visits in the follow-up year among patients with public insurance and 
private insurance. We determined the number of ED visits in Year 1 that corresponded 
to a 50% or greater chance of frequent ED use in Year 2, in order to suggest a cutoff 
for a parsimonious prediction rule.  
 
Statistical Software. We used the R software package (version 3.1.1)34 for analysis, 
using the following packages: “gdata”,35 “randomForest”,32 “rpart”,31 “rpart.plot”,36 
“glmnet”,30 “ROCR”,37 “caret”,38 “e1071”,33 “ggplot2”,39 “data.table”,40 “leaps”,41 
“stats”,34 “pROC”.42  
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CHAPTER THREE 
RESULTS 
 
List of Potential Predictor Variables. We reviewed 17 recent papers1-5, 6-8, 12-16, 25, 43-45 
and identified 4 categories of factors that are associated with frequent ED use: (1) 
demographics; (2) prior healthcare utilization history; (3) co-morbidities; and (4) 
medication history. The demographic variables were race, ethnicity, insurance status, 
and having access to a primary care physician. Healthcare utilization history variables 
were (1) total number of ED visits and (2) total number of outpatient visits. The co-
morbidities variables were: (1) food and other allergies; (2) congenital lung 
abnormalities, and (3) gastro-esophageal reflux disease (GERD). For medication 
history we had the variable Controller-to-asthma medication ratio. We interviewed 
five physicians: three general pediatricians, one pediatric pulmonologist, and one 
pediatric emergency medicine physician. We compiled a list of 74 potential predictors 
from the literature review and the interviews. (Table 1)   
 
Operationalization of Variables in EHR. We were able to operationalize 36 out of 74 
predictors from Weill Cornell Physician Organization’s outpatient electronic health 
record (EHR) data. Based on data available in the EHR, we added 16 additional 
asthma-related variables such as medical and psychiatric comorbidities, specific 
allergies, and use of asthma medication delivery devices. The final number of 
predictors was 52.  
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Table 1. List of variables from literature review, physician interviews, and 
operationalized predictors. 
 
 
Proposed Variable 
Operationalized 
Variable 
DEMOGRAPHICS Individual   Age Age 
 Sex Sex 
 Race* Race 
 Ethnicity* Ethnicity 
 Insurance Status* Insurance Type 
 Socioeconomic Status  Borough of New York 
 Frequent change of address - 
 Yes/No for 
Homelessness/Living in a 
shelter 
- 
 Yes/No and Count to 
Recommend to Social 
Worker 
- 
    Family Characteristics    Single parent family - 
 Degree of parental health 
education - 
 Family history of allergic 
disease - 
    Zip Code Characteristics   Population density of zip 
code - 
 Degree of education - 
 Zip code Borough of New York 
    Environmental Factors   Yes/No for Exposure to 
secondhand smoke - 
 Yes/No for parents/guardians 
who smoke - 
 Yes/No to dust exposure  - 
 Allergens/Trigger exposure 
at home  Allergy List (Categories) 
   CLINICAL DATA Disease Factors  
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 IgE levels IgE Test 
 Asthma Severity  - 
 Abnormal PFTs (Pulmonary 
Function Tests)  - 
 FEV1 (Forced Expiratory 
Volume in 1 second) - 
 BMI BMI 
 Respiratory Viral Panel - 
 Allergy Test Allergy List (Categories) 
 Yes/No to Flu Shot past year - 
   MEDICATIONS Medication refill history - 
 Controller-to-Asthma 
medication ratio* - 
 Yes/No for Inpatient steroids - 
 Yes/No for outpatient 
steroids - 
 Xolair  - 
 - Yes/No for Asthma 
Medication Device 
 Advair Yes/No for Inhaled Drug 
Combination 
 Symbicort Yes/No for Inhaled Drug 
Combination 
 Albuterol use Yes/No for Inhaled 
Rescue Medication 
 Yes/No for prescription beta 
agonists 
Yes/No for Inhaled 
Rescue, Yes/No for 
Inhaled Drug 
Combination 
 Yes/No for inhaled steroids Yes/No for Inhaled 
Steroids 
 Flovent (Fluticasone) Yes/No for Inhaled 
Steroids 
 Qvar (Beclomethasone) Yes/No for Inhaled 
Steroids 
 Pulmicort (Budesonide) Yes/No for Inhaled 
Steroids 
 Yes/No for leukotriene 
inhibitors Yes/No for Leukotrienes 
 Montelukast (Singulair) Yes/No for Leukotrienes 
 - Yes/No for Mast Cell 
Stabilizer 
 Yes/No for oral steroids Yes/No for Oral Steroids 
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 Prednisolone Yes/No for Oral Steroids 
 
Prednisone Yes/No for Oral Steroids 
 
- Yes/No for Other 
Medications 
   COMORBIDITIES PMCA  PMCA (Stringent) 
Classification 
 - Yes/No for Allergic 
Rhinitis 
 Food and other allergies* Yes/No for Allergies 
 - Yes/No for Anxiety 
 - Yes/No for Bronchiolitis 
 - Yes/No for Bronchitis 
 Chronic Lung Disease Yes/No for 
Bronchopulmonary 
Dysplasia 
 Broncho-pulmonary 
Dysplasia 
Yes/No for 
Bronchopulmonary 
Dysplasia 
 Congenital lung 
abnormalities* 
Yes/No for 
Bronchopulmonary 
Dysplasia 
 
- Yes/No for Depression 
 
Eczema Yes/No for Eczema 
 
- Yes/No for Gastrostomy 
Tube 
 
Gastroesophageal Reflux 
Disease (GERD)* Yes/No for GERD 
 
- Yes/No for Pneumonia 
 
Premature birth Yes/No for Premature 
Birth 
 
Tracheostomy Dependent Yes/No for 
Tracheostomy 
 
- Yes/No for Vocal Cord 
Dysfunction 
   PRIOR HEALTH 
SERVICE 
UTILIZATION 
Ambulatory & ED 
 
 Total number of ED Visits* 2013 (Year 1) and 2014 
(Year 2) ED visits 
 Total number of ED Visits 
for Asthma  - 
 Outpatient Visits, Total* Year 1 and 2 Outpatient 
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Visits 
 Outpatient Visits, General 
Pediatrics - 
 Outpatient Visits, Pediatric 
Pulmonology/Allergist - 
 Missed Outpatient Visits for 
Primary Care & Specialist - 
 Yes/No for Having PCP* Yes/No for Has PCP 
 Ratio of ED Visit/Primary 
Care Visit - 
 Reliance on ED for Asthma 
Care - 
 Time of ED Visit - 
 Weekend/Weekday ED Visit - 
    Inpatient   Total Inpatient Admissions Year 1 and 2 Inpatient 
Visits 
 Admission to ICU for 
Asthma  - 
 Admission to ICU, Total 
Number - 
 Intubation for Asthma - 
 Inpatient Admissions from 
ED - 
 Number of Inpatient days - 
 Number of ICU days - 
 O2 levels during Inpatient 
stay - 
 Maximal level of respiratory 
support required - 
* Indicates variables found in literature review.  
 
Description of Cohort. There were 2691 patients in the final dataset. Median age was 
6 [IQI: 3 – 11]. Sixty percent of patients were male, and 40% were female. Racially, 
36% were White, 13% were Black or African American, 6% were Asian, and 1% 
American Indian or Alaska National. A large group (29%) fell into the category Other 
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Combinations not Described. Almost 22% identified as having Hispanic or Latin or 
Spanish origin. For borough of residence, 46% lived in Manhattan, 14% lived in 
Queens, 13% in Brooklyn, 12% in the Bronx, and 1% in Staten Island. The remaining 
14% lived outside New York City. For insurance type, 67% of patients had private 
insurance, 28% were publicly insured, and the remaining 5% were unknown. A 
majority of patients had a primary care physician (78%). However, for almost 21% of 
the patients whether they had access to a primary care doctor was unknown.  
 
Prevalence of Frequent ED users. There were 184 (6.8%) frequent ED users (≥ 2 
visits) during Year 2 among the 2691 individuals in the full dataset. There were 98 
(7.3%) frequent ED users in the training data, and 86 (6.3%) frequent ED users in the 
test data.  
 
Bivariate Associations between Predictors and Frequent ED use. Several predictor 
variables were significantly associated with frequent ED use in the follow-up year. 
(Table 2) Females were more likely than males to be frequent ED users. Patients who 
racially identify as “Black or African American” or “Other” were more than 50% 
more likely to use the ED frequently. Other factors that contribute to a high ED use 
are: having Hispanic/Latino/Spanish origin, living in the Bronx or Queens, having 
public insurance, being a medically complex patient, being obese, and high health 
utilization in the baseline year. Among medical and psychiatric comorbidities, patients 
with allergic rhinitis, eczema, and pneumonia were more likely to be frequent ED 
users. Additionally, patients who have had gastrostomy tubes or tracheostomy for care 
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were at an elevated risk for ED use. Interestingly, frequent ED users were twice as 
likely to be allergic to cockroaches, but less likely to have mold or tree allergies. For 
medication usage, frequent ED users used asthma medication devices such as spacers 
and nebulizers almost 25% more than non-frequent ED users, took more inhaled 
rescue drugs, mast cell stabilizers, and other medications. (Table 2) 
 
Table 2. Descriptive statistics of variables classified on the basis of frequent ED use.  
 Variable < 2 visits (N = 
2507) 
> = 2 visits 
(N = 184) 
p- value 
Age Age 6 [3-11] 6 [3-11] ns § 
     
Sex Female 996 (40%) 87 (47%) 0.05 ¶ 
 Male 1511 (60%) 97 (53%) 	  
     
Race American 
Indian/Alaskan 
0 (0%) 5 (3%) < 0.001 ¶ 
 Asian 151 (6%) 3 (2%)  
 Black or African 
American 
323 (13%) 36 (20%)  
 White 940 (37%) 30 (16%)  
 Other 696 (28%) 93 (50%)  
 Declined 354 (14%) 17 (9%)  
 Unknown 43 (2%) 0 (0%)  
     
Ethnicity Hispanic/Latino/
Spanish Origin 
520 (21%) 69 (38%) < 0.001 ¶ 
 Not 
Hispanic/Latino/
Spanish 
1461 (58%) 80 (43%)  
 Declined 421 (17%) 19 (10%)  
 Unknown 105 (4%) 16 (9%)  
     
Borough of  
New York 
Bronx 303 (12%) 33 (18%) < 0.001 ¶ 
 Brooklyn 327 (13%) 19 (10%)  
 Manhattan 1149 (46%) 76 (41%)  
 Queens 336 (13%) 48 (26%)  
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 Staten Island 24 (1%) 0 (0%)  
 Other 368 (15%) 8 (5%)  
     
Insurance Type Private 1749 (70%) 59 (32%) < 0.001 ¶ 
 Public 635 (25%) 122 (66%)  
 Unknown 123 (5%) 3 (2%)  
     
Has Primary 
Care Physician 
(PCP) 
Does not have 
PCP 
16 (1%) 0 (0%) < 0.01 ¶ 
 Has PCP 1980 (79%) 130 (71%)  
 Unknown 511 (20%) 54 (29%)  
     
Utilization 
Baseline Year 
(Year 1) 
ED Visits 0 [0 - 0] 1 [0.75 - 3] < 0.001 § 
 Inpatient Visits 0 [0 - 0] 0 [0 - 1] < 0.001 § 
 Outpatient Visits 3 [1 - 6] 6 [3 - 11] < 0.001 § 
 Other Visits 0 [0 - 0] 0 [0 - 0] ns § 
     
PMCA (More 
stringent) 
Chronic Disease, 
Medically 
Complex 
277 (11%) 42 (23%) < 0.001 ¶ 
 Chronic Disease 795 (32%) 72 (39%)  
	   No Chronic 
Disease 
1306 (52%) 67 (36%)  
 Other 129 (5%) 3 (2%)  
 	   	   	   	  
BMI Normal 2080 (83%) 158 (86%) < 0.01 ¶ 
 Overweight 123 (5%) 8 (5%)  
 Obese 72 (3%) 11 (6%)  
 Unknown 232 (9%) 7 (3%)  
     
IgE Test Abnormal 54 (2%) 6 (3%) ns ¶ 
 Normal 47 (2%) 3 (2%)  
 Not Sent 2406 (96%) 175 (95%)  
     
Psychiatric 
Comorbidities 
Anxiety 1 (0.03%) 1 (0.5%) ns § 
 Depression 12 (0.5%) 2 (1%) ns § 
     
Medical 
Comorbidities † 
Allergic Rhinitis 415 (16%) 39 (21%) < 0.01 § 
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 Bronchiolitis 213 (8.5%) 15 (8%) ns § 
 Bronchitis 17 (1%) 0 (0%) ns § 
 Broncho-
pulmonary 
Dysplasia 
69 (3%) 7 (4%) ns § 
 Eczema 156 (6%) 18 (10%) < 0.01 § 
 Pneumonia 132 (5%) 17 (9%) < 0.05 § 
 Premature Birth 35 (1%) 3 (2%) ns § 
 Vocal Cord 
Dysfunction 
11 (0.4%) 3 (2%) ns § 
     
Technology 
Dependence 
Gastrostomy 
Tube 
40 (1.5%) 9 (5%) < 0.001 § 
 Tracheostomy 38 (1.5%) 7 (4%) < 0.01 § 
     
Allergies Animal 253 (12%) 16 (9%) ns § 
 Chemical 19 (0.8%) 3 (2%) ns § 
 Cockroach 47 (2%) 8 (4%) < 0.01 § 
 Drug 294 (12%) 27 (15%) ns § 
 Dust 140 (6%) 14 (8%) ns § 
 Food 506 (20%) 42 (23%) ns § 
 Fungus 5 (0.2%) 0 (0%) ns § 
 Herbal 12 (0.5%) 0 (0%) ns § 
 Latex 13 (0.5%) 2 (1%) ns § 
 Mold 1574 (62%) 102 (55%) < 0.05 § 
 Other 111 (4.4%) 9 (5%) ns § 
 Pollen 115 (5%) 11 (6%) ns § 
 Seasonal 20 (0.7%) 2 (1%) ns § 
 Trees 1663 (66%) 109 (59%) < 0.05 § 
     
Medication 
Usage * 
Asthma 
Medication 
Device 
565 (23%) 54 (29%) < 0.05 § 
 Inhaled Drug 
Combination 
76 (3%) 8 (4%) ns § 
 Inhaled Rescue 2274 (91%) 177 (96%) < 0.05 § 
 Inhaled Steroids 1037 (41%) 82 (45%) ns § 
 Leukotrienes 294 (12%) 22 (12%) ns § 
 Mast Cell 
Stabilizer 
4 (0.2%) 2 (1%) < 0.05 § 
 Oral Steroids 528 (21%) 43 (23%) ns § 
 Other 
Medications 
1848 (74%) 157 (85%) < 0.001 § 
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All values are either Median [Interquartile Range] or N (% of patients within the 
category of ED use in Year 2). 
§ Pearson correlation. ED visits in Year 2 treated as a continuous variable. 
¶ Chi-square test. ED visits in year 2 treated as 2-valued categorical variable (>= 2 or 
< 2 ED visits in Year 2). 
ns Not significant at p-values < 0.05  
† GERD and IgA were available to the predictive models but were 0% prevalent in 
both groups of ED use. 
 
* Medication Usage Classification: 
Asthma Medication Device = Aerochamber, Nebulizer, Nessi Spacer 
Inhaled Drug Combination = Advair Diskus, Advair HFA, Budesonide-Formoterol, 
Combivent, Fluticasone-Salmeterol, Ipratropium-Albuterol, Symbicort 
Inhaled Rescue = Albuterol, Ipratropium bromide, Ventolin, Xopenex  
Inhaled Steroids = Beclomethasone, Budesonide, Flovent, Fluticasone, Pulmicort, 
Pulmoneb, Qvar 
Leukotriene = Montelukast, Singulair  
Mast Cell Stabilizer = Cromolyn 
Oral Steroids = Orapred, Prednisolone, Prednisone, Dexamethasone 
Other Medications = Non-asthma prescription and non-prescription medications 
 
Predictability of Frequent ED Use. Qualitatively, all seven algorithms performed 
similarly. The area under the receiver operating curve (AUC) ranged from 0.81-0.87 
for all algorithms excluding CART, indicating very good predictability. The 
performance of CART was fair with AUC of 0.66. The positive predictive value was 
mostly poor (< 60%), with the exception of LASSO, which had good performance 
(70%). The sensitivity was uniformly poor (16-27%). Calibration was good to fair (13-
20%), with the exception of Random Forest, which had excellent calibration (4.1%). 
Classification error ranged from 5.8-6.6%. (Table 3) 
 
The LASSO Model. The two variables selected by the LASSO technique (Table 3) 
were (1) number of ED visits in the baseline year, and (2) having public insurance. In 
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comparison to other models, it had the highest AUC (0.87), highest positive predictive 
value (70%) and lowest classification error (5.8%). Similar to other models it had poor 
sensitivity (16%) and calibration (20%).  
 
Two Variable Model. The two variable logistic regression model based on the best 
subsets algorithm yielded the same variables in its final model as the LASSO. 
Compared to the LASSO, it had similar AUC (0.86) and classification error (5.9), 
better sensitivity (23%), and better calibration (13%). However, it had poorer positive 
predictive value (56%). The final variables in the pruned tree of the CART model 
were the same ones as the LASSO and two-variable best subsets. The three-variable 
best subsets model also had the two aforementioned variables, along with a third one 
(i.e. use of mast cell stabilizer).  
 
Selection of Final Model. We selected a final model that had two predictors: (1) 
Number of ED visits in Year 1; and (2) Type of Insurance. Both of these variables 
emerged significant in the final parsimonious models of all the predictive algorithms.  
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Table 3. Evaluation of Predictive Modeling Techniques on a test set of 1346 patients. 
Technique Number 
of 
Variables 
AUC Calibr
ation 
(%) 
Classifi
cation 
Error 
(%) 
Sens
itivit
y 
(%) 
PPV 
(%) 
Variable Names  
Logistic 
Regression, 
Best 
Subsets 
1 0.84 13 5.9 27 59 Number of ED 
visits in Year 1  
 2 0.86 13 5.9 23 56 Number of ED 
visits in Year 1, 
Insurance Type 
= Public  
 3 0.86 14 6.1 23 56 Number of ED 
visits in Year 1, 
Insurance Type 
= Public, Use of 
Mast Cell 
Stabilizer = Yes 
Lasso 2 0.87 20 5.8 16 70 Number of ED 
visits in Year 1, 
Insurance Type 
= Public  
Random 
Forest 
all (52) 0.83 4.1 6.4 19 52 - 
CART 2 0.66 15 6.6 24 48 Number of ED 
visits in Year 1, 
Insurance Type 
= Public  
Support 
Vector 
Machines 
all (52) 0.81 14 6.0 19 62 - 
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The final plots illustrate frequent ED utilization in the follow-up year compared to the 
number of ED visits in the baseline year, separately among individuals with private 
and public insurance. Among the publicly insured, any individual with 4 or more ED 
visits in the baseline year had a 50% or higher probability of frequent ED use in Year 
2 (Figure 1). Individuals, who visited the ED 4 or more times in the baseline year, 
used the ED, on average, 4 times in the following year. However, among the privately 
insured, 50% or higher probability of frequent ED use in Year 2 was attained at 6 or 
more ED visits during the baseline year (Figure 2). Individuals, who visited the ED 6 
or more times in the baseline year, used the ED, on average, 11 times in the following 
year.  
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Figure 1. Relationship between number of ED visits in year 1 and observed 
proportion of frequent ED use in year 2 among publicly insured patients. The X 
axis denotes the number of ED visits in baseline Year 1. The Y axis denotes the 
corresponding proportion of patients (%) who were frequent ED users in the following 
year. Points indicate observed proportion of frequent ED users. The diagonal line 
shows the slope of the line using linear modeling. The error bars are the 95% 
confidence interval of the binomial distribution of the observed proportion. 
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Figure 2. Relationship between number of ED visits in year 1 and observed 
proportion of frequent ED use in year 2 among privately insured patients. Points 
indicate observed proportion of frequent ED users. The X axis denotes the number of 
ED visits in baseline Year 1. The Y axis denotes the corresponding proportion of 
patients (%) who were frequent ED users in the following year. Points indicate 
observed proportion of frequent ED users. The diagonal line shows the slope of the 
line using linear modeling. The error bars are the 95% confidence interval of the 
binomial distribution of the observed proportion. 
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Threshold Selection Table. We explored the relationship between ED use in Years 1 
and 2, and explored score thresholds that might be used for care management 
enrollment (Table 4). For example, if a care management team has the capacity to 
enroll 80 publicly insured patients then it would use a threshold of three. Among the 
79 enrolled, the team can expect about 48 patients (61%) to be frequent ED users. If 
the care management team has a lower enrollment capacity, then they can select a 
higher score threshold, i.e. enroll fewer patients. Subsequently, for greater enrollment 
capacities, a lower score threshold can be picked, thereby enrolling more patients. 
Based on care management capacity, a healthcare organization can select the number 
of people they wish to enroll. 
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Table 4. Threshold selection table for care management enrollment recommendations. 
 
Public Insurance 
 
# ED visits 
in Year 1 
(Score 
Threshold) 
Number 
to 
Enroll 
“Hits” 
(pts with 
> 2 ED 
visits in 
Year 2) 
PPV Sensitivity Total # 
of ED 
visits in 
Year 2 
Mean # 
of ED 
visits 
per 
enrollee 
in Year 
2 
6+ 20 17 85 14 89 4.5 
5 30 24 80 20 109 3.6 
4 49 36 73 30 185 3.8 
3 79 48 61 39 281 3.6 
2 150 68 45 56 391 2.6 
1 315 97 31 80 527 1.7 
0 757 122 16 100 1026 1.4 	  
Private Insurance 	  
# ED visits 
in Year 1 
(Score 
Threshold) 
Number 
to 
Enroll 
"Hits" 
(pts with 
> 2 ED 
visits in 
Year 2) 
PPV Sensitivity Total # 
of ED 
visits in 
Year 2 
Mean # 
of ED 
visits 
per 
enrollee 
in Year 
2 
6+ 3 3 100 5 32 10.7 
5 6 4 67 7 37 6.2 
4 15 7 47 12 41 2.7 
3 29 9 31 15 71 2.4 
2 85 18 21 31 157 1.8 
1 267 39 15 66 291 1.1 
0 1808 59 3 100 1906 1.1 
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CHAPTER FOUR 
DISCUSSION AND FUTURE DIRECTIONS 
Summary. We found several clinical, demographic and healthcare utilization factors 
that were significantly associated with future frequent ED use among children with 
asthma. We developed a predictive model that identified children at high risk for 
future frequent ED use, based on prior ED visit history and insurance status (Public 
versus Private). This model performed as well as multivariable models and machine 
learning techniques.  Publicly insured patients who visited the ED four or more times 
in a year had a 50% or higher probability of frequent ED use in the following year; the 
threshold for privately insured patients was six or more ED visits per year. 
 
Significance. Several important findings emerged from our work. First, upon bivariate 
analysis, we found significant associations between frequent ED use and many of the 
potential predictor variables, including race, ethnicity, borough of New York City 
where patient lives, insurance type, access to Primary Care Physician, history of high 
healthcare utilization (ED, inpatient, and outpatient visits), medical complexity, BMI, 
medical comorbidities, technology dependence, allergies, and use of certain 
medications such as inhaled rescue drugs and mast cell stabilizers. Many of these 
results are consistent with previous findings in the literature. For example, among 
children in California, African Americans and Latinos were 82% and 23% 
respectively more likely than Whites to visit the ED for asthma symptoms.13 As 
another example, a study that looked at the use of health services by insurance status 
among children with asthma from seven New England hospitals found that publicly 
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insured children used the ED more frequently than privately insured children.43 
Several studies have demonstrated that there are increases in asthma-related ED visits 
with decreasing SES.13,43 One explanation is that regions of lower income are more 
susceptible to high levels of aeroallergens, thereby increasing the likelihood of 
asthma-related ED visits.44 Finally, among children admitted to a New England 
hospital with a primary diagnosis of asthma, a history of previous ED visits was a 
significant predictor of subsequent ED visits.12 
 
Second, despite the large number of significant bivariate associations, we built 
a predictive model that only required two variables.  It is unclear why there was little 
additional predictive information from the remaining variables. One possible 
explanation could be that some of these variables are collinear with ED use; indirectly 
reflected in patient’s health utilization patterns, and therefore did not discretely appear 
in the final models.  
 
Third, although many of the bivariate associations were not useful for 
predictions, they do provide valuable insight into the kinds of interventions that might 
be effective for high ED utilization among children with asthma. Some of these factors 
such as allergies, obesity, and medical complexity can be specifically addressed 
through clinical care interventions like providing allergy medications, or enrolling 
patients and caregivers in obesity counseling services. Other factors, such as access to 
a primary care physician, residing in areas of New York City that have high levels of 
air pollutants such as midtown and downtown Manhattan, and along busy freeways in 
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the outer boroughs,45 and problems associated with low socioeconomic status need 
more than just clinical interventions. For example, patients who don’t have access to a 
primary care physician may benefit from additional assistance from social workers to 
find free or subsidized clinics.  Care managers can look at some of these predictors 
that emerged significant in our bivariate analysis to anticipate the healthcare needs of 
this population, i.e. which patients need only clinical care interventions, and which 
need more than that. 
  
Fourth, our work demonstrates that EHRs can be valuable source of research 
data. Many studies use discharge and insurance claims data from statewide or national 
databases.22 This approach has several strengths: it has lower data collection costs 
compared to medical record abstraction or surveys, includes information on uninsured 
patients not available from third party payers, and provides greater reliability than self-
reported medical expenditures. However, there are inconsistencies in how providers, 
government agencies, and payers report specific data elements. Additionally, there 
may be hospital-specific errors in data reporting that can lead to data quality problems. 
An alternative approach is to use data from electronic health records (EHRs). In 
addition to billing codes, EHRs contain detailed clinical information such as test 
results, severity of illness, behavioral risk factors, and free text.23 In our study, many 
significant variables that were extracted from the EHR are not typically reported in 
administrative data. Examples of such variables are different types of allergies, IgE 
test results, and psychiatric and medical comorbidities.  
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Implications for Clinical Care and Care Management. Our results have implications 
for clinical practice. For example, healthcare providers can review the insurance status 
and prior ED utilization history of each patient and make recommendations to care 
management teams. For example, if a publicly insured patient visited the ED four or 
more times the previous year, he/she has a 50% or higher likelihood of being a 
frequent ED user, and could be recommended for enrollment into care management. 
Additionally, we created a score threshold table for publicly and privately insured 
patients that may be used for care management enrollment based on available 
resources. The table gives the care management team a benchmark for comparison. 
Our model cannot identify which of the enrolled patients are going to be frequent ED 
users -- thus it is imperative to design tailor-made care plans for each of the 
individuals enrolled. Results from the bivariate analysis can be good indicators of the 
kinds of needs that patients may have and could be taken into account when creating 
individualized care plans. Overall, our study provides recommendations to clinicians 
and care managers about who could potentially be enrolled in care management 
programs.  
 
Limitations. There were several important limitations to this study. First, despite the 
high AUC values of the techniques, the positive predictive values and sensitivities 
were poor.  
 
Second, our data only captures ED visits to New York Presbyterian-Cornell 
Medical Center. One cannot rule out the possibility of patients going to other 
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emergency departments closer to their residences at the time of exacerbations or for 
asthma management in general.46-48 Data from other hospital EDs were not available to 
us at the time of this study. Gathering health utilization data from regional health 
information exchanges may provide a more comprehensive picture of each patient’s 
ED visits and may help predictive models better detect these events, potentially 
improving predictive accuracies. 
 
Third, we were unable to operationalize certain concepts that typically appear 
in free text rather than in structured fields. For example, there are no structured fields 
to indicate whether a patient is homeless or lives in a shelter. Conceptually, not having 
a stable residence can have repercussions for disease management, and increase ED 
utilization for care.49 Successful operationalization of these concepts by using natural 
language processing could have made the dataset even more robust and helped 
improve predictive accuracies.  
Fourth, the generalizability of these predictions is unclear. Since our source of 
data is one medical center in New York City, it is unknown how well our model would 
work in other locations across the city and other geographic regions in the country.  
 
Future Opportunities. There are several future opportunities that follow from our work. 
First, the results of the predictive modeling should be implemented and the 
recommendations for care management should be applied in practice Subsequently, 
the outcomes could be evaluated for future programmatic modifications. 
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Second, the value of other data sources such as health information exchanges 
and personal health records should be explored further for predictive modeling. These 
may help in creating more robust datasets that may improve predictive accuracies.  
 
Third, other healthcare organizations could use patient data from their own 
centers and perform predictive modeling to see if the results are consistent with ours. 
This can address the issue of reproducibility, and can also assess the generalizability 
of our findings.    
 
Fourth, future research can compare the predictability of frequent ED use 
among pediatric asthma patients with other common chronic diseases among children 
such as epilepsy, diabetes, and cystic fibrosis.50 
 
Finally, use of predictive modeling in healthcare must overcome the 
‘impactibility’ problem.51 Even if sophisticated algorithms can accurately identify 
high-risk patients for readmissions, the extent to which providers can successfully 
intervene is unclear because of current disease management approaches and resource 
constraints.52 Disease management organizations may prioritize managing patients 
more likely to respond to preventive care, such as patients with ambulatory case 
sensitive conditions, rather than extremely high-risk patients for whom preventing 
rehospitalization is unlikely because of factors such as disease severity, mental health 
diagnoses, severe addictions, demographic characteristics, etc.51,52 Assessing 
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efficiencies of these approaches can provide novel insights into how predictive 
modeling can be better used to create greater impact in healthcare. 
 
Conclusion. We found that publicly insured patients who use the ED four or more 
times in the current year have a high likelihood of continued frequent ED use (≥ 2 
times) in the following year. Privately insured patients who use the ED six or more 
times in the current year have continued high ED utilization in the following year. Our 
two variable model can help identify a cohort of patients who may benefit from care 
management interventions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  35	  
BIBLIOGRAPHY 
1. Asthma & Children Fact Sheet. American Lung Association. 
http://www.lung.org/lung-disease/asthma/resources/facts-and-figures/asthma-
children-fact-sheet.html. Accessed August 1, 2015. 
 
2. Asthma. Centers for Disease Control and Prevention. 
http://www.cdc.gov/nchs/fastats/asthma.htm. Accessed August 3, 2015. 
 
 
3. Trends in Asthma Prevalence, Health Care Use, and Mortality in the United 
States, 2001-2010. Centers for Disease Control and Prevention. 
http://www.cdc.gov/nchs/data/databriefs/db94.htm. Accessed August 3, 2015. 
 
4. Asthma in the US. Centers for Disease Control and Prevention. 
http://www.cdc.gov/vitalsigns/asthma/. Accessed August 1, 2015. 
 
 
5. Pearson WS, Goates SA, Harrykissoon SD, Miller SA. State-Based Medicaid 
Costs for Pediatric Asthma Emergency Department Visits. Prev Chronic Dis. 
2014;11: 140139. 
 
6. Szefler SJ, Zeiger RS, Haselkorn T, et al. Economic burden of impairment in 
children with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 
2011;107(2):110-119.e1. 
 
 
7. Trachtenberg AJ, Dik N, Chateau D, Katz A. Inequities in ambulatory care and 
the relationship between socioeconomic status and respiratory hospitalizations: 
a population-based study of a Canadian city. Ann Fam Med. 2014;12(5):402-7. 
 
8. Enard KR, Ganelin DM. Reducing preventable emergency department 
utilization and costs by using community health workers as patient navigators. 
J Healthc Manag. 2013;58(6):412-27. 
 
 
9. Sweeney L, Halpert A, Waranoff J. Patient-centered management of complex 
patients can reduce costs without shortening life. Am J Manag Care. 
2007;13(2):84-92. 
 
10. McCarthy D, Cohen A, Johnson MB. Gaining ground: care management 
programs to reduce hospital admissions and readmissions among chronically ill 
and vulnerable patients. Case Study Series Synthesis The Commonwealth Fund. 
2013. 
 
	  	  36	  
11. Billings J, Blunt I, Steventon A, Georghiou T, Lewis G, Bardsley M. 
Development of a predictive model to identify inpatients at risk of re-
admission within 30 days of discharge (PARR-30). BMJ Open. 2012;2(4). 
 
12. Tolomeo C, Savrin C, Heinzer M, Bazzy-asaad A. Predictors of asthma-related 
pediatric emergency department visits and hospitalizations. J Asthma. 
2009;46(8):829-34. 
 
13. Wright K. Disparities and predictors of emergency department use among 
California's African American, Latino, and White children, aged 1-11 years, 
with asthma. Ethn Dis. 2009;19(1):71-7. 
 
14. Steppuhn H, Langen U, Scheidt-nave C, Keil T. Major comorbid conditions in 
asthma and association with asthma-related hospitalizations and emergency 
department admissions in adults: results from the German National Health 
Telephone Interview Survey (GEDA) 2010. BMC Pulm Med. 2013;13:46. 
 
15. Ferris TG, Crain EF, Oken E, et al. Insurance and quality of care for children 
with acute asthma. Ambul Pediatr. 2001;1(5):267-74. 
 
16. Schatz M, Zeiger RS, Vollmer WM, et al. The controller-to-total asthma 
medication ratio is associated with patient-centered as well as utilization 
outcomes. Chest. 2006;130(1):43-50. 
 
17. Kansagara D, Englander H, Salanitro A, et al. Risk prediction models for 
hospital readmission: a systematic review. JAMA. 2011;306(15):1688-98. 
 
18. Shulan M, Gao K, Moore CD. Predicting 30-day all-cause hospital 
readmissions. Health Care Manag Sci. 2013;16(2):167-75. 
 
19. Yu S, van Esbroeck A, Farooq F, Fung G, Anand V, Krishnapuram B. 
Predicting Readmission Risk With Institution Specific Prediction Models. In: 
Proceedings of the IEEE International Conference on Healthcare Informatics 
2013. 2013. p. 551-556. 
  
20. Mather JF, Fortunato GJ, Ash JL, Davis MJ, Kumar A. Prediction of 
pneumonia 30-day readmissions: a single-center attempt to increase model 
performance. Respir Care. 2014;59(2):199-208. 
 
21. Natale J, Wang S, Taylor J. A Decision Tree Model for Predicting Heart 
Failure Patient Readmissions. In: Krishnamurthy A, Chan WKV. (eds.) 
Proceedings of the 2013 Industrial and Systems Engineering Research 
Conference. 2013. 
  
	  	  37	  
22. Ohno-machado L. Realizing the full potential of electronic health records: the 
role of natural language processing. J Am Med Inform Assoc. 2011;18(5):539. 
 
23. Why Predictive Modeling in Healthcare Requires A Data Warehouse. Health 
Catalyst. https://www.healthcatalyst.com/wp-content/uploads/2014/02/Why-
predictive-modeling-healthcare-requires-a-data-warehouse.pdf. Accessed 
January 28, 2015. 
 
24. Moorman JE, Rudd RA, Johnson CA, et al. National surveillance for asthma--
United States, 1980-2004. MMWR Surveill Summ. 2007;56(8):1-54. 
 
25. Simon TD, Cawthon ML, Stanford S, et al. Pediatric medical complexity 
algorithm: a new method to stratify children by medical complexity. 
Pediatrics. 2014;133(6):e1647-54. 
 
26. Hunt KA, Weber EJ, Showstack JA, Colby DC, Callaham ML. Characteristics 
of frequent users of emergency departments. Ann Emerg Med. 2006;48(1):1-8. 
 
27. Byrne M, Murphy AW, Plunkett PK, Mcgee HM, Murray A, Bury G. Frequent 
attenders to an emergency department: a study of primary health care use, 
medical profile, and psychosocial characteristics. Ann Emerg Med. 
2003;41(3):309-18. 
 
28. Ledoux Y, Minner P. Occasional and frequent repeaters in a psychiatric 
emergency room. Soc Psychiatry Psychiatr Epidemiol. 2006;41(2):115-21. 
 
29. Hastie T, Tibshirani R, Friedman JH. The elements of statistical learning: data 
mining, inference, and prediction, 2nd ed. New York, NY: Springer, 2009. 
 
30. Friedman JH, Hastie T, Tibshirani R. Regularization paths for generalized 
linear models via coordinate descent. J Stat Softw. 2010;33(1):1-22. 
 
31. Rpart: Recursive Partitioning. R Package version 4.1-4. [computer program] 
2015. 
 
32. Liaw A, Wiener M. Classification and Regression by randomForest. R News. 
2002;2:18-22. 
 
33. e1071: Misc Functions of the Department of Statistics (e1071), TU Wien. R 
Package version 1.6-2 [computer program] 2014. 
 
34. R Core Team (2014). R: A language and environment for statistical computing. 
R Foundation for Statistical Computing, Vienna, Austria. URL http://www.R-
project.org/. 
 
	  	  38	  
35. Warnes GR, Bolker B, Gorjanc G, et al. gdata: Various R programming tools 
for data manipulation. R package version 2.13.3. 2014. 
 
36. Milborrow S. rpart.plot: Plot rpart Models. R package version 1.5.2. 2015. 
 
37. Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier 
performance in R. Bioinformatics. 2005;21(20):3940-1. 
 
38. Kuhn M. caret: Classification and regression training. R package version 6.0-
47. 
 
39. Wickham H. ggplot2: elegant graphics for data analysis. Springer New York, 
2009. 
 
40. Dowle M, Short T, Lianoglou S. data.table: Extension of data.frame. R 
package version 1.9.4. 2014. 
  
41. Lumley T. leaps: regression subset selection. R package version 2.9. 2009. 
 
42. Xavier R, Turck N, Hainard A, et al. pROC: an open-source packager for R 
and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77. 
 
43. Ortega AN, Belanger KD, Paltiel AD, Horwitz SM, Bracken MB, Leaderer BP. 
Use of health services by insurance status among children with asthma. Med 
Care. 2001;39(10):1065-74. 
 
44. Heffernan PM. Socioeconomic status, asthma, and emergency department use 
in Ontario, Canada. [master’s thesis]. St John’s, Canada: Memorial University 
of Newfoundland; 2012. 
 
45. The New York City community air survey. New York City Department of 
Health and Mental Hygiene. 
http://www.nyc.gov/html/doh/downloads/pdf/eode/comm-air-survey-report.pdf. 
Accessed August 1, 2015. 
 
46. Shapiro JS, Johnson SA, Angiollilo J, Fleischman W, Onyile A, Kuperman G. 
Health information exchange improves identification of frequent emergency 
department users. Health Aff (Millwood). 2013;32(12):2193-8. 
 
47. Bourgeois FC, Olson KL, Mandl KD. Patients treated at multiple acute health 
care facilities: quantifying information fragmentation. Arch Intern Med. 
2010;170(22):1989-95. 
 
	  	  39	  
48. Finnell JT, Overhage JM, Grannis S. All health care is not local: an evaluation 
of the distribution of Emergency Department care delivered in Indiana. AMIA 
Annu Symp Proc. 2011;2011:409-16. 
 
49. Ku BS, Scott KC, Kertesz SG, Pitts SR. Factors associated with use of urban 
emergency departments by the U.S. homeless population. Public Health Rep. 
2010;125(3):398-405. 
 
50. Torpy JM, Campbell A, Glass RM. JAMA patient page. Chronic diseases of 
children. JAMA. 2010;303(7):682. 
 
51. Lewis GH. "Impactibility models": identifying the subgroup of high-risk 
patients most amenable to hospital-avoidance programs. Milbank Q. 
2010;88(2):240-55. 
 
52. Wharam JF, Weiner JP. The promise and peril of healthcare forecasting. Am J 
Manag Care. 2012;18(3):e82-5. 
 
